To compare the action of 2 different doses of an additive dexmedetomidine added to 0.5% buivacaine and 2% Lignocaine, Adrenaline in Ultrasound Guided Block for forearm surgeries.

To compare the efficacy of 2 different doses of dexmedetomidine added to 0.5% buivacaine and 2% Lignocaine, Adrenaline in Ultrasound Guided Block for forearm surgeries. - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064063

Enrollment

Registered

2024-03-13

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: dexmedetomidine: Dexmedetomidine 0.5mcg/kg is added as adjuvant to bupivacine and lignocain total 30.5ml of drug is given locally for ultrasoud guided block and effect is observed till

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing elective upper limb surgeries. Haemodynamically stable patients. Availability of an informed consent.

Exclusion criteria

Exclusion criteria: Patients with ASA physical status III or more. Patients with nerve injury. Patients who have known allergies to any of test drugs. Patients with coagulation disorders or on anticoagulant drugs. Patients with cardiac disease and respiratory disease.

Design outcomes

Primary

Measure	Time frame
to check the efficacy of upper limb blockTimepoint: every 15 minutes till the end of the surgery from the point of administration of block	—

Secondary

Measure	Time frame
time of onset of sensory & motor block and the duration of analgesia of the block.Timepoint: every 15 minutes till the end of the surgery from the point of administration of block	—

Countries

India

Contacts

Public ContactWaseema Kabeer

Dr.D.Y.Patil medical college, Hospital and Research center

shilpasale@gmail.com7251888789

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026